Clinical Trial – Adult ages 18-55 years with Attention Deficit Hyperactivity Disorder

Clinical Trial – Adult ages 18-55 years with Attention Deficit Hyperactivity Disorder

Attention Deficit – unable to pay attention, easily distracted

This Clinical Trial is looking for adults ages 18-55 with moderate to severe attention-deficit hyperactivity disorder (ADHD).

Patients must have

  1. Significant problems with inattention and/or hyperactivity/impulsivity.

Patients must not have

  1. Other significant medical or psychiatric disorders.
  2. Bipolar disorder, schizophrenia, or other psychotic disorder.
  3. Severe obesity (BMI greater than or equal to 39).
  4. Seizure disorder.
  5. Hypertension that is not controlled with treatment.
  6. Untreated thyroid disease.
  7. Tourette’s disorder or tics.
  8. Significant heart problems.
  9. Current use of any psychiatric medicines other than stimulants.
  10. Poor response in the past to amphetamines or methylphenidate taken in sufficient doses.
  11. Drug or alcohol abuse.
  12. Current use of street drugs with inability to stay off them.

The new medicine being used is a form of amphetamine.

See if you qualify. Please contact:

Call our office at 586-254-0707, or fill out a request for us to contact you.

Located in the Detroit metro area, Dr. Sangal of Sleep and Attention Disorders Institute sees patients from all over SE Michigan. Patients see him from communities like Warren, Shelby, Sterling Heights, Rochester Hills, Madison Heights, and Troy. Dr. Sangal is experienced in working with attention deficit disorders.

We treat every patient and clinical trial participant with respect, concern and consideration. To learn more about how you may participate in this study, please contact:

Sleep & Attention Disorders Institute

586-254-0707

44344 Dequindre Rd Suite 360

Sterling Heights, MI 48314

New medicine for daytime sleepiness

A new medicine for daytime sleepiness was approved this year. It should arrive in pharmacies in the next few months. Its name is SunosiR (or solriamfetol). It blocks reuptake of dopamine (DA) and norepinephrine (NE) into nerve cells that release these. As a result, DA and NE levels increase in the area between nerve cells…

CPAP Adherence and How to Improve It

Continuous Positive Airway Pressure (CPAP) is the best treatment for obstructive sleep apnea (OSA). Unfortunately, only 59% of patients prescribed CPAP in the USA actually use it. Yet, being adherent to CPAP use is crucial in controlling OSA and its complications. The complications include sleepiness and fatigue, memory and concentration problems, high blood pressure, atrial…

Sleeping with half the brain

Sleeping with half the brain – is that even possible? Yes, it is. Many birds and aquatic mammals sleep with half the brain at any time, according to Scientific American (June 2019) [https://www.scientificamerican.com/magazine/sa/2019/06-01/?redirect=1] Mammals that live in water (whales, dolphins, porpoises) might drown if they fall asleep. They cannot breathe when under water. Therefore, they…

Schedule An Appointment Today

44344 Dequindre Rd Suite 360
Sterling Heights, MI 48314
click here for directions